Incannex Healthcare (IXHL) Interest Expenses (2024 - 2025)
Incannex Healthcare's (IXHL) quarterly Interest Expenses came in at -$5000.0 in Q4 2025, up 82.14% year-on-year from -$2745.1 in Q4 2024, and little changed quarter-over-quarter from -$5000.0 in Q3 2025.
Incannex Healthcare (IXHL) Interest Expenses (2024 - 2025) Analysis & Trends
Incannex Healthcare has disclosed Interest Expenses across 2 years of filings, most recently posting -$5000.0 for Q4 2025.
- Interest Expenses for Q4 2025 came in at -$5000.0, up 82.14% year-over-year; the trailing twelve-month figure through Mar 2026 was -$10000.0 (down 113.16% YoY), and the FY2025 annual result was $303000.0, changed N/A from the prior year.
- Interest Expenses came in at -$5000.0 for Q4 2025 at Incannex Healthcare, roughly flat from -$5000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $132000.0 in Q1 2025 to a low of -$28000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.00 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 20.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 4.86 Mn |
| 10 | Incannex Healthcare | 45.81 Mn | 45.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Sep 30, 2025 | -5,000.00 |
| Sep 30, 2025 | -5,000.00 |
| Mar 31, 2025 | 132,000.00 |
| Mar 31, 2025 | 132,000.00 |
| Dec 31, 2024 | -28,000.00 |
| Dec 31, 2024 | -28,000.00 |
| Sep 30, 2024 | -28,000.00 |
| Sep 30, 2024 | -28,000.00 |